2021 Q4 Form 10-Q Financial Statement

#000181939421000015 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $27.09M $27.66M $25.07M
YoY Change 14.84% 10.29%
Cost Of Revenue $15.84M $13.47M $10.01M
YoY Change 56.68% 34.63%
Gross Profit $11.25M $14.18M $15.07M
YoY Change -16.55% -5.87%
Gross Profit Margin 41.53% 51.28% 60.09%
Selling, General & Admin $78.75M $44.05M $9.942M
YoY Change 580.27% 343.1%
% of Gross Profit 700.11% 310.65% 65.99%
Research & Development $27.78M $14.48M $3.861M
YoY Change 489.81% 275.14%
% of Gross Profit 246.98% 102.14% 25.63%
Depreciation & Amortization $1.703M $1.500M $1.200M
YoY Change 37.34% 25.0%
% of Gross Profit 15.14% 10.58% 7.96%
Operating Expenses $106.5M $58.54M $13.80M
YoY Change 554.23% 324.09%
Operating Profit -$95.28M -$44.36M $1.263M
YoY Change 3296.79% -3611.96%
Interest Expense $1.239M $91.00K $339.0K
YoY Change -511.63% -73.16%
% of Operating Profit 26.84%
Other Income/Expense, Net -$67.24M -$123.6M -$340.0K
YoY Change -2241400.0% 36252.65%
Pretax Income -$161.3M -$168.0M $923.0K
YoY Change 5097.55% -18296.64%
Income Tax -$290.0K $34.00K $17.00K
% Of Pretax Income 1.84%
Net Earnings -$161.0M -$168.0M $906.0K
YoY Change 5045.09% -18641.83%
Net Earnings / Revenue -594.34% -607.45% 3.61%
Basic Earnings Per Share -$0.86 $0.00
Diluted Earnings Per Share -$654.6K -$0.86 $0.00
COMMON SHARES
Basic Shares Outstanding 242.5M shares 196.5M shares 32.55M shares
Diluted Shares Outstanding 196.5M shares 32.55M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $404.5M $323.0M
YoY Change 680.04%
Cash & Equivalents $139.5M $148.9M $48.94M
Short-Term Investments $264.9M $174.2M
Other Short-Term Assets $16.78M $11.86M
YoY Change
Inventory $5.593M $3.989M
Prepaid Expenses
Receivables $10.88M $9.572M
Other Receivables $0.00 $0.00
Total Short-Term Assets $437.7M $348.4M
YoY Change 602.88%
LONG-TERM ASSETS
Property, Plant & Equipment $14.12M $11.38M
YoY Change 71.96%
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $263.7M $290.9M
YoY Change
Other Assets $3.696M $2.716M
YoY Change 169.98%
Total Long-Term Assets $281.5M $305.0M
YoY Change 2838.44%
TOTAL ASSETS
Total Short-Term Assets $437.7M $348.4M
Total Long-Term Assets $281.5M $305.0M
Total Assets $719.2M $653.4M
YoY Change 900.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.23M $6.848M
YoY Change 256.06%
Accrued Expenses $2.754M $2.503M
YoY Change
Deferred Revenue $11.07M $8.903M
YoY Change 140.43%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $33.33M $24.53M
YoY Change 43.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $262.0K $278.0K
YoY Change -21.79%
Total Long-Term Liabilities $262.0K $278.0K
YoY Change -94.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.33M $24.53M
Total Long-Term Liabilities $262.0K $278.0K
Total Liabilities $451.0M $447.7M
YoY Change 1488.97%
SHAREHOLDERS EQUITY
Retained Earnings -$468.1M -$307.1M
YoY Change 260.05%
Common Stock $25.00K $24.00K
YoY Change 525.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $268.2M $205.7M -$119.4M
YoY Change
Total Liabilities & Shareholders Equity $719.2M $653.4M
YoY Change 900.91%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$161.0M -$168.0M $906.0K
YoY Change 5045.09% -18641.83%
Depreciation, Depletion And Amortization $1.703M $1.500M $1.200M
YoY Change 37.34% 25.0%
Cash From Operating Activities -$17.72M -$18.46M -$7.140M
YoY Change -600.06% 158.54%
INVESTING ACTIVITIES
Capital Expenditures -$2.241M -$2.187M -$3.644M
YoY Change 80.73% -39.98%
Acquisitions
YoY Change
Other Investing Activities -$66.35M -$466.5M $0.00
YoY Change
Cash From Investing Activities -$68.59M -$468.7M -$3.644M
YoY Change 5431.13% 12760.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 76.78M 593.9M 49.59M
YoY Change 8704.93% 1097.66%
NET CHANGE
Cash From Operating Activities -17.72M -18.46M -7.140M
Cash From Investing Activities -68.59M -468.7M -3.644M
Cash From Financing Activities 76.78M 593.9M 49.59M
Net Change In Cash -9.524M 106.8M 38.81M
YoY Change -399.97% 175.24%
FREE CASH FLOW
Cash From Operating Activities -$17.72M -$18.46M -$7.140M
Capital Expenditures -$2.241M -$2.187M -$3.644M
Free Cash Flow -$15.48M -$16.27M -$3.496M
YoY Change -423.56% 365.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001819394
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
Matterport, Inc./DE
CY2021Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2021Q3 us-gaap Assets Current
AssetsCurrent
348445000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39790
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1695048
dei Entity Address Address Line1
EntityAddressAddressLine1
352 East Java Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Sunnyvale
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94089
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
641-2241
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
174168000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 USD
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
242504260 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
148853000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51850000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
468000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
400000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
182000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
799000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9572000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3924000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
3989000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
3646000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11395000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2453000 USD
CY2020Q4 mttr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
6995000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
24532000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
62273000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11377000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8210000 USD
CY2021Q3 us-gaap Other Long Term Investments
OtherLongTermInvestments
290900000 USD
CY2020Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
0 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2716000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1369000 USD
CY2021Q3 us-gaap Assets
Assets
653438000 USD
CY2020Q4 us-gaap Assets
Assets
71852000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6848000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3434000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8215000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8903000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4606000 USD
CY2021Q3 mttr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
8781000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23250000 USD
CY2021Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
334389000 USD
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4502000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
210000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
297000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
278000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
335000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
447712000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
28384000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
0.0001 USD
CY2021Q3 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
0.0001 USD
CY2021Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
30000000 shares
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
125405000 shares
CY2021Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
124979000 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
124979000 shares
CY2021Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
0 USD
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
166131000 USD
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
164168000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
640000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
230680000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
242413000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
242413000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38981000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38981000 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
24000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
512808000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9159000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-38000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
135000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-307068000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129998000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
205726000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-120700000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
653438000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71852000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27655000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25074000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
84087000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62297000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13474000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10008000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35364000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27836000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
14181000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
15066000 USD
us-gaap Gross Profit
GrossProfit
48723000 USD
us-gaap Gross Profit
GrossProfit
34461000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14484000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3861000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27599000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13003000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44053000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9942000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73612000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30215000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
58537000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
13803000 USD
us-gaap Operating Expenses
OperatingExpenses
101211000 USD
us-gaap Operating Expenses
OperatingExpenses
43218000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44356000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1263000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-52488000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8757000 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
550000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
572000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
16000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
91000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
339000 USD
us-gaap Interest Expense
InterestExpense
676000 USD
us-gaap Interest Expense
InterestExpense
1197000 USD
CY2021Q3 mttr Reverse Recapitalization Transaction Costs Expensed
ReverseRecapitalizationTransactionCostsExpensed
565000 USD
CY2020Q3 mttr Reverse Recapitalization Transaction Costs Expensed
ReverseRecapitalizationTransactionCostsExpensed
0 USD
mttr Reverse Recapitalization Transaction Costs Expensed
ReverseRecapitalizationTransactionCostsExpensed
565000 USD
mttr Reverse Recapitalization Transaction Costs Expensed
ReverseRecapitalizationTransactionCostsExpensed
0 USD
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
24176000 USD
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
24176000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-98478000 USD
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-98478000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-839000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1186000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-903000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-123599000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-340000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-124509000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2084000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-167955000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
923000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-176997000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10841000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-167989000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
906000 USD
us-gaap Net Income Loss
NetIncomeLoss
-177070000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10892000 USD
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
906000 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
906000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
196478000 shares
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-167989000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-167989000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
0 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-177070000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-177070000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10892000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10892000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
196478000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32334000 shares
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-16000 USD
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32552000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32552000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93061000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93061000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32334000 shares
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
99000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-79000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-20000 USD
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-182000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-94000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-168187000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1005000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-177243000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10912000 USD
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
124979000 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
164168000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-120700000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2872000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
789000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
740000 USD
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
124979000 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
164168000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-122070000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-6209000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
52000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
553000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
713000 USD
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
124979000 shares
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
164168000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-126961000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-167989000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-198000 USD
CY2021Q3 mttr Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
52000 shares
CY2021Q3 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
293000 USD
CY2021Q3 mttr Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
125031000 shares
CY2021Q3 mttr Temporary Equity Value Conversion Of Convertible Securities
TemporaryEquityValueConversionOfConvertibleSecurities
164461000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
164461000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
357000 USD
CY2021Q3 mttr Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
539897000 USD
CY2021Q3 mttr Adjustments To Additional Paid In Capital Contingent Earn Out Liability
AdjustmentsToAdditionalPaidInCapitalContingentEarnOutLiability
235911000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32070000 USD
CY2021Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
205726000 USD
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
98542000 shares
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
110978000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-109629000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-8108000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-98000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
620000 USD
CY2020Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
98542000 shares
CY2020Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
110978000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-117215000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3690000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21000 USD
CY2020Q1 mttr Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
-4729000 shares
CY2020Q1 mttr Temporary Equity Value Conversion Of Convertible Securities
TemporaryEquityValueConversionOfConvertibleSecurities
-9501000 USD
CY2020Q2 mttr Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
21708000 shares
CY2020Q2 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
43689000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
625000 USD
CY2020Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
124979000 shares
CY2020Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
164168000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-120250000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
906000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
99000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
138000 USD
CY2021Q3 mttr Adjustments To Additional Paid In Capital Options Settled With Cash
AdjustmentsToAdditionalPaidInCapitalOptionsSettledWithCash
554000 USD
CY2020Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
438000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
664000 USD
CY2020Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
124979000 shares
CY2020Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
164168000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-119435000 USD
CY2021Q3 mttr Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
4.1193
us-gaap Net Income Loss
NetIncomeLoss
-177070000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10892000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4121000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3538000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
135000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
172000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-413000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
31997000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1794000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
24176000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-98478000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
mttr Reverse Recapitalization Transaction Costs Expensed
ReverseRecapitalizationTransactionCostsExpensed
565000 USD
mttr Reverse Recapitalization Transaction Costs Expensed
ReverseRecapitalizationTransactionCostsExpensed
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-210000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-954000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
460000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
581000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-193000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6100000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7097000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
342000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2260000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7699000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
965000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3427000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1692000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4503000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2817000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1442000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2516000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21091000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7140000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
536000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20000 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
5233000 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3624000 USD
mttr Payments To Acquire Debt Securities Available For Sale Investments
PaymentsToAcquireDebtSecuritiesAvailableForSaleInvestments
466466000 USD
mttr Payments To Acquire Debt Securities Available For Sale Investments
PaymentsToAcquireDebtSecuritiesAvailableForSaleInvestments
0 USD
mttr Payments To Acquire Debt Securities Available For Sale Convertible Notes
PaymentsToAcquireDebtSecuritiesAvailableForSaleConvertibleNotes
1000000 USD
mttr Payments To Acquire Debt Securities Available For Sale Convertible Notes
PaymentsToAcquireDebtSecuritiesAvailableForSaleConvertibleNotes
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-473235000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3644000 USD
mttr Proceeds From Reverse Recapitalization
ProceedsFromReverseRecapitalization
612854000 USD
mttr Proceeds From Reverse Recapitalization
ProceedsFromReverseRecapitalization
0 USD
mttr Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
9813000 USD
mttr Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
0 USD
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
0 USD
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
43689000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1696000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
5221000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
189000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
8457000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13067000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
6974000 USD
mttr Payments For Settlement Of Vested Stock Options
PaymentsForSettlementOfVestedStockOptions
0 USD
mttr Payments For Settlement Of Vested Stock Options
PaymentsForSettlementOfVestedStockOptions
554000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
438000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
591670000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49590000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
97344000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
38806000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-273000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-22000 USD
mttr Reverse Recapitalization Contingent Earnout Liability Recognized
ReverseRecapitalizationContingentEarnoutLiabilityRecognized
231627000 USD
mttr Reverse Recapitalization Contingent Earnout Liability Recognized
ReverseRecapitalizationContingentEarnoutLiabilityRecognized
0 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
164461000 USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52250000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10152000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
149321000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48936000 USD
us-gaap Interest Paid Net
InterestPaidNet
753000 USD
us-gaap Interest Paid Net
InterestPaidNet
851000 USD
mttr Reverse Recapitalization Transaction Costs Incurred But Not Yet Paid
ReverseRecapitalizationTransactionCostsIncurredButNotYetPaid
200000 USD
mttr Reverse Recapitalization Transaction Costs Incurred But Not Yet Paid
ReverseRecapitalizationTransactionCostsIncurredButNotYetPaid
0 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationCertain prior-period amounts have been reclassified in the accompanying Condensed Consolidated Financial Statements and Notes thereto in order to conform to the current period presentation.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts and disclosures in the condensed consolidated financial statements and accompanying notes. Significant estimates include assumptions related to the fair value of common stock and other assumptions used to measure stock-based compensation, valuation of deferred tax assets, the estimate of net realizable value of inventory, allowance for doubtful accounts, the fair value of common stock warrants, public and private warrants liability, and e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arn-out</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares, and the determination of stand-alone selling price (“SSP”) of various performance obligations. As of September 30, 2021, future impact of the COVID-19 pandemic on the Company’s operational and financial performance will depend on certain developments, including the duration and spread of the pandemic, impact on the Company’s subscribers and their spending habits, impact on the Company’s marketing efforts, and effect on the Company’s suppliers, all of which are uncertain and cannot be predicted with certainty. As a result, many of the Company’s estimates and assumptions required increased judgment and these estimates may change materially in future periods.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management evaluates its estimates and assumptions on an ongoing basis using historical experience and various other factors, including the current economic environment and the impact of COVID-19, which management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company adjusts such estimates and assumptions when dictated by facts and circumstances. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods. Actual results may differ materially from those estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:18pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, investments, and accounts receivable. The Company maintains its cash balances in accounts held by major banks and financial institutions located in the United States. Such bank deposits from time to time may be exposed to credit risk in excess of the Federal Deposit Insurance Corporation insurance limit, and the Company considers such risk to be minimal. </span></div><div style="margin-top:12pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest only in high-quality credit instruments and maintain our cash and cash equivalents and available-for-sale investments in fixed income securities. Management believes that the financial institutions that hold our investments are financially sound and, accordingly, are subject to minimal credit risk. Deposits held with banks may exceed the amount of insurance provided on such deposits.</span></div><div style="margin-top:12pt;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s accounts receivable is derived from customers located both inside and outside the United States. The Company mitigates its credit risks by performing ongoing credit evaluations of the financial condition of its customers and requires advance payment from customers in certain circumstances. The Company generally does not require collateral from its customers.</span></div>
CY2021Q3 us-gaap Credit Card Receivables
CreditCardReceivables
600000 USD
CY2020Q4 us-gaap Credit Card Receivables
CreditCardReceivables
800000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
400000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
200000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
800000 USD
CY2020Q4 mttr Reverse Recapitalization Deferred Transaction Costs
ReverseRecapitalizationDeferredTransactionCosts
100000 USD
CY2021Q3 mttr Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
36300000 USD
CY2021Q3 mttr Adjustments To Additional Paid In Capital Recapitalization Transaction Costs
AdjustmentsToAdditionalPaidInCapitalRecapitalizationTransactionCosts
35700000 USD
CY2021Q3 mttr Reverse Capitalization Transaction Costs Paid
ReverseCapitalizationTransactionCostsPaid
600000 USD
CY2021Q3 mttr Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
23460000 shares
CY2021Q3 us-gaap Advertising Expense
AdvertisingExpense
2300000 USD
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
900000 USD
us-gaap Advertising Expense
AdvertisingExpense
5800000 USD
us-gaap Advertising Expense
AdvertisingExpense
3000000 USD
CY2021Q3 mttr Proceeds From Reverse Recapitalization Transaction Gross
ProceedsFromReverseRecapitalizationTransactionGross
640100000 USD
CY2021Q3 mttr Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
345100000 USD
CY2021Q3 mttr Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
36300000 USD
CY2021Q3 mttr Adjustments To Additional Paid In Capital Recapitalization Transaction Costs
AdjustmentsToAdditionalPaidInCapitalRecapitalizationTransactionCosts
35700000 USD
CY2021Q3 mttr Reverse Recapitalization Transaction Costs Expensed
ReverseRecapitalizationTransactionCostsExpensed
600000 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 mttr Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
4.1193
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
29500000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
241956000 shares
CY2021Q3 mttr Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
23460000 shares
CY2021Q3 mttr Reverse Recapitalization Contingent Consideration Equity Shares Earnout Period
ReverseRecapitalizationContingentConsiderationEquitySharesEarnoutPeriod
P180D
CY2021Q3 us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
27655000 USD
CY2020Q3 us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
25074000 USD
us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
84087000 USD
us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
62297000 USD
CY2021Q3 us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
27655000 USD
CY2020Q3 us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
25074000 USD
us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
84087000 USD
us-gaap Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
62297000 USD
CY2021Q3 mttr Accounts Receivable Net Excluding Unbilled Receivables
AccountsReceivableNetExcludingUnbilledReceivables
7793000 USD
CY2020Q4 mttr Accounts Receivable Net Excluding Unbilled Receivables
AccountsReceivableNetExcludingUnbilledReceivables
2700000 USD
CY2021Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1779000 USD
CY2020Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1224000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
9113000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4903000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4100000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1900000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22700000 USD
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
20100000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
337000 USD
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
309000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
159000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
32000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
566000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
799000 USD
CY2020Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
340000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
460000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
581000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1077000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
12000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
182000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
906000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
182000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
906000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1026000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
538000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1480000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2219000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1483000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
889000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
3989000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
3646000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27929000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20653000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16552000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12443000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11377000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8210000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1500000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1200000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3500000 USD
CY2021Q3 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
3300000 USD
CY2020Q3 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
1200000 USD
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
6700000 USD
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
3700000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3208000 USD
CY2021Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1400000 USD
CY2020Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1100000 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
3800000 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
3300000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2503000 USD
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
945000 USD
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1164000 USD
CY2021Q3 mttr Reverse Recapitalization Accrued Transaction Costs
ReverseRecapitalizationAccruedTransactionCosts
200000 USD
CY2020Q4 mttr Reverse Recapitalization Accrued Transaction Costs
ReverseRecapitalizationAccruedTransactionCosts
135000 USD
CY2021Q3 mttr Accrued Liabilities Other Miscellaneous Current
AccruedLiabilitiesOtherMiscellaneousCurrent
5133000 USD
CY2020Q4 mttr Accrued Liabilities Other Miscellaneous Current
AccruedLiabilitiesOtherMiscellaneousCurrent
2488000 USD
CY2021Q3 mttr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
8781000 USD
CY2020Q4 mttr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
6995000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
466257000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
100000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
194000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
466163000 USD
CY2021Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
174176000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
174167000 USD
CY2021Q3 mttr Debt Securities Available For Sale Maturity After One Through Three Years Amortized Cost
DebtSecuritiesAvailableForSaleMaturityAfterOneThroughThreeYearsAmortizedCost
292081000 USD
CY2021Q3 mttr Debt Securities Available For Sale Maturity After One Through Three Years Fair Value
DebtSecuritiesAvailableForSaleMaturityAfterOneThroughThreeYearsFairValue
291996000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
466257000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
466163000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
13067000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
350000 USD
CY2020Q4 mttr Long Term Debt Net Of Unamortized Debt Discount
LongTermDebtNetOfUnamortizedDebtDiscount
12717000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8215000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
4502000 USD
CY2021Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
400000 USD
CY2020Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1300000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1900000 USD
CY2021Q3 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
153000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
318000 USD
CY2021Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
8313000 USD
CY2021Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
8631000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1301000 USD
CY2021Q3 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
5221000 USD
CY2021Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
6522000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1339000 USD
CY2021Q3 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
165000 USD
CY2021Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1504000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1306000 USD
CY2021Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1459000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
207000 USD
CY2021Q3 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
0 USD
CY2021Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
207000 USD
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
4471000 USD
CY2021Q3 us-gaap Purchase Obligation
PurchaseObligation
13852000 USD
CY2021Q3 us-gaap Contractual Obligation
ContractualObligation
18323000 USD
CY2021Q3 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2020Q4 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
124979000 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
124979000 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
164168000 USD
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
166131000 USD
CY2021Q3 mttr Stock Issued During Period Shares Reverse Recapitalization
StockIssuedDuringPeriodSharesReverseRecapitalization
72500000 shares
CY2021Q3 mttr Proceeds From Reverse Recapitalization Transaction Gross
ProceedsFromReverseRecapitalizationTransactionGross
640100000 USD
CY2021Q3 mttr Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
36300000 USD
CY2021Q3 mttr Adjustments To Additional Paid In Capital Recapitalization Transaction Costs
AdjustmentsToAdditionalPaidInCapitalRecapitalizationTransactionCosts
35700000 USD
CY2021Q3 mttr Reverse Recapitalization Transaction Costs Expensed
ReverseRecapitalizationTransactionCostsExpensed
600000 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
232700000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 mttr Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
670000000 shares
CY2021Q3 mttr Common Stock And Preferred Stock Par Or Stated Value Per Share
CommonStockAndPreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
640000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
242000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
113126000 shares
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-173000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-20000 USD
CY2021Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
11350000 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11350000 shares
CY2021Q3 mttr Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
0 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11350000 shares
CY2021Q3 mttr Class Of Warrant Or Right Grant Date Fair Value
ClassOfWarrantOrRightGrantDateFairValue
7.78
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
64127000 USD
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
24176000 USD
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
88303000 USD
CY2021Q3 mttr Derivative Instrument Contingent Consideration Liability Shares
DerivativeInstrumentContingentConsiderationLiabilityShares
23460000 shares
CY2021Q3 mttr Reverse Recapitalization Number Of Tranches Of Earn Out Shares
ReverseRecapitalizationNumberOfTranchesOfEarnOutShares
6 tranche
CY2021Q3 mttr Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays
10 D
CY2021Q3 mttr Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Consecutive Trading Days
DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdConsecutiveTradingDays
30 D
CY2021Q3 mttr Derivative Instrument Reverse Recapitalization Contingent Consideration Equity Earnout Period Threshold Business Days
DerivativeInstrumentReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdBusinessDays
180 D
CY2021Q3 mttr Derivative Instrument Contingent Consideration Liability Fair Value
DerivativeInstrumentContingentConsiderationLiabilityFairValue
294800000 USD
CY2021Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
231600000 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
231627000 USD
mttr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Reallocation Of Earn Out Shares To Earn Out Liability Upon Forfeitures
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReallocationOfEarnOutSharesToEarnOutLiabilityUponForfeitures
4284000 USD
mttr Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Fair Value Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityFairValueAdjustment
98478000 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
334389000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
49206000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.62
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
245565000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2673000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.7
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
3402000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
33210000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
43131000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.63
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
788467000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
27493000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
504540000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4400000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30738000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
630000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31997000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1794000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1332000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
34000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1526000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
115000 USD
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
32070000 USD
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
664000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
33523000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
1909000 USD
CY2021Q3 mttr Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
4.1193
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-167989000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
906000 USD
us-gaap Net Income Loss
NetIncomeLoss
-177070000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10892000 USD
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
906000 USD
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
906000 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 USD
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-167989000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-167989000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
0 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-177070000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-177070000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
196478000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32552000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-10892000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10892000 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
196478000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32552000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
93061000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93061000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32334000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32334000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
81671000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
180349000 shares

Files In Submission

Name View Source Status
0001819394-21-000015-index-headers.html Edgar Link pending
0001819394-21-000015-index.html Edgar Link pending
0001819394-21-000015.txt Edgar Link pending
0001819394-21-000015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mttr-20210930.htm Edgar Link pending
mttr-20210930.xsd Edgar Link pending
mttr-20210930_cal.xml Edgar Link unprocessable
mttr-20210930_def.xml Edgar Link unprocessable
mttr-20210930_htm.xml Edgar Link completed
mttr-20210930_lab.xml Edgar Link unprocessable
mttr-20210930_pre.xml Edgar Link unprocessable
mttr-exhibit3111110.htm Edgar Link pending
mttr-exhibit3121110.htm Edgar Link pending
mttr-exhibit3211110.htm Edgar Link pending
mttr-exhibit3221110.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending